Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
First glucokinase-activator (GKA) approval outside mainland China Approval supports a differentiated approach to T ype 2 diabetes (T2D) management Hong Kong will serve as H ua Medicine's launchpad for international market expansion SHANGHAI and HONG...
ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy
Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease. SAN FRANCISCO and SHANGHAI, March 2, 2026 /PRNewswire/ -- ReviR Therapeutics, a clinical-stage biotechnology company pioneering AI-driven...
Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair®
PHILADELPHIA, March 2, 2026 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. ("LongBio"), a clinical-stage biotech company focused on discovery and development of biologics targeting allergic and autoimmune diseases, proudly announced positive...
Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit
LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing therapies grounded in human biology, today announced that it will deliver a company presentation at the BIO Investment & Growth...
MDJM LTD Announces Journey to the West Officially Enters Production
A Prestigious European Production Team Leads the Project LONDON, March 2, 2026 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that the animated short...
Pinnacle Food Group Limited Announces Investor Day 2026 and Non-Deal Roadshow
VANCOUVER, BC, March 2, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven smart farming and bio-engineering company, providing integrated farming-as-a-service solutions and developing biology-enabled platforms to...
Yatsen Announces Fourth Quarter and Full Year 2025 Financial Results
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on March 2, 2026 GUANGZHOU, China, March 2, 2026 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its...
MiniMax Announces Full Year 2025 Financial Results
HONG KONG, March 2, 2026 /PRNewswire/ -- MiniMax Group Inc. ("MiniMax" or the "Company"; HKEX: 00100), a global AI foundation model company, today announced its financial results for the year ended December 31, 2025. FY 202 5 Key Highlights Total...
RX Japan GK Announces FaW TOKYO 2026, Japan's Largest Fashion Trade Show
TOKYO, March 2, 2026 /PRNewswire/ -- RX Japan GK announces the opening of visitor registration for the 29th edition of FaW TOKYO -- FASHION WORLD TOKYO 2026 APRIL, one of Japan's largest fashion trade shows, taking place from April 8-10, 2026, at...
Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis
SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today...